跳至主要内容
临床试验/JPRN-UMIN000013244
JPRN-UMIN000013244已完成未知

Effects of miglitol on glucose metabolism and gut-derived hormones in type 2 diabetes who lose response to sitagliptin - The beneficial effects of add-on therapy with miglitol in type 2 diabetes mellitus treated with sitagliptin

Hyogo college of medicine0 个研究点目标入组 10 人开始时间: 2014年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with serious heart, liver, kidney diseases 2. Pregnant and/or breathbeeding, child-bearing potential women. 3. Patients who is complicated with a malignant tumor 4. Patients with severe infection, perioperative, severe injury 5. Patients who are undergoing treatment with an arufa-glucosidase inhibitor or a rapid-acting insulin secretagogue 6. Other patients whom their physicians in charge considered unsuitable for inclusion in this study a. Patients who has laparotomy or ileus b. Patients with chronic bowel diseases with malabsorption c. Patients who has the disease which is deteriorated with increase of gas in bowel d. Patients with intolerance in Lactose e. Patient with diabetic retinopathy to need photocoagulation or vitreous surgery f. Patients with serious diabetic complications including progressed neutopathy

研究者

相似试验